Epigenetic compound screening uncovers small molecules for re-activation of latent HIV-1
A. Zutz, L. Chen, F. Sippl, C. Schölz
This study screens epigenetic compounds to identify new latency reversing agents (LRAs) for reactivating latent HIV-1, finding two novel compounds with high reactivation efficiency and low toxicity.
bioRxiv · Aug 21, 2020Pharmacology & Toxicology